Pharma manufacturer expands with purchase of facility in FranceApril 3, 2020A U.S.-based manufacturer of canine and equine joint health pharmaceuticals has expanded its capabilities with the purchase of a European active pharmaceutical ingredient (API) manufacturing plant.
SPONSORED CONTENTWhere unique needs meet innovative scienceFind precise, innovative solutions for your patients' unique needs + Learn More